These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Potential anti-depressive effects of thyrotropin releasing hormone (TRH) and its analogues. Ogawa N; Mizuno S; Mori A; Nukina I; Ota Z; Yamamoto M Peptides; 1984; 5(4):743-6. PubMed ID: 6436797 [TBL] [Abstract][Full Text] [Related]
23. Ventral root depolarization and spinal reflex augmentation by a TRH analog in rat spinal cord. Ono H; Fukuda H Neuropharmacology; 1982 Aug; 21(8):739-44. PubMed ID: 6811965 [TBL] [Abstract][Full Text] [Related]
24. Metabolic abnormalities caused by 3-acetylpyridine in the cerebral motor regions of rats: partial recovery by thyrotropin-releasing hormone. Kinoshita K; Watanabe Y; Asai H; Matsuoka Y Jpn J Pharmacol; 2000 Apr; 82(4):295-300. PubMed ID: 10875748 [TBL] [Abstract][Full Text] [Related]
25. Intracerebroventricular injection of a TRH analogue, gamma-butyrolactone-gamma-carbonyl-L-histidyl-prolinamide, induces gastric lesions and gastric acid stimulation in rats. Maeda-Hagiwara M; Watanabe H Naunyn Schmiedebergs Arch Pharmacol; 1985 Aug; 330(2):142-6. PubMed ID: 3930976 [TBL] [Abstract][Full Text] [Related]
26. Effects of thyrotropin releasing hormone and its analogues on unconsciousness following head injury in mice. Tanaka K; Ogawa N; Chou H; Mori A; Yanaihara N Regul Pept; 1992 Mar; 38(2):129-33. PubMed ID: 1574607 [TBL] [Abstract][Full Text] [Related]
27. Mechanism of the hyperthermic effect of the novel thyrotropin-releasing hormone analogue Na-((1S,2R)-2-methyl-4-oxocyclopentylcarbonyl)-L-histidyl-L- prolinamide monohydrate in mice with reserpine-induced hypothermia. Matsushita M; Yonemori F; Ohta A; Iwata K Arzneimittelforschung; 1995 Jun; 45(6):708-11. PubMed ID: 7646576 [TBL] [Abstract][Full Text] [Related]
28. L-6-ketopiperidine-2-carbonyl-L-leucyl-L-proline amide as a novel thyrotropin releasing hormone analogue with improving effects on impaired central nervous systems functions. Oka M; Ochi Y; Furukawa K; Ito T; Miura Y; Karasawa T; Kadokawa T Arzneimittelforschung; 1989 Mar; 39(3):297-303. PubMed ID: 2547386 [TBL] [Abstract][Full Text] [Related]
29. Radioimmunoassay for an analog of thyrotrophin-releasing hormone, gamma-butyrolactone-gamma-carbonyl-L-histidyl-L-prolinamide (DN-1417). Shiota K; Miyake A; Tsunoda C; Oka Y; Nagawa Y; Nakayama R J Immunol Methods; 1982; 51(1):69-80. PubMed ID: 6809831 [TBL] [Abstract][Full Text] [Related]
30. Synthesis and central nervous system actions of thyrotropin-releasing hormone analogues containing a dihydroorotic acid moiety. Suzuki M; Sugano H; Matsumoto K; Yamamura M; Ishida R J Med Chem; 1990 Aug; 33(8):2130-7. PubMed ID: 2115588 [TBL] [Abstract][Full Text] [Related]
31. In vitro thyrotrophin release with thyrotropin-releasing hormone and an analogue, DN-1417. Shiota K; Yoshida K; Noguchi C; Nakayama R Acta Endocrinol (Copenh); 1984 May; 106(1):71-8. PubMed ID: 6428117 [TBL] [Abstract][Full Text] [Related]
32. Effects of a TRH analog (DN-1417) and TRH-T on the electroconvulsive threshold. Nakamura J; Uchimura N; Yamada S; Tsutsumi T; Ishibashi K; Kojima H; Inanaga K Kurume Med J; 1983; 30 Suppl():S65-72. PubMed ID: 6434802 [No Abstract] [Full Text] [Related]
33. Absorption of gamma-butyrolactone-gamma-carbonyl-L-histidyl-L-prolinamide citrate (DN-1417), an analog of thyrotropin-releasing hormone, in rats and dogs. Yokohama S; Yoshioka T; Kitamori N J Pharmacobiodyn; 1984 Aug; 7(8):527-35. PubMed ID: 6439851 [TBL] [Abstract][Full Text] [Related]
34. [Synthesis and pharmacological action of TRH analog peptide (Taltirelin)]. Yamamura M; Suzuki M; Matsumoto K Nihon Yakurigaku Zasshi; 1997 Oct; 110 Suppl 1():33P-38P. PubMed ID: 9503402 [TBL] [Abstract][Full Text] [Related]
35. Effects of thyrotrophin-releasing hormone tartrate and its sustained release formulation on cerebral glucose metabolism in aged rats. Nakayama T; Nagai Y J Pharm Pharmacol; 1997 Sep; 49(9):884-91. PubMed ID: 9306256 [TBL] [Abstract][Full Text] [Related]
36. Effect of thyrotropin-releasing hormone (TRH) on local cerebral glucose utilization, by the autoradiographic 2-deoxy[14C]glucose method, in conscious and pentobarbitalized rats. Nagai Y; Narumi S; Nagawa Y; Sakurada O; Ueno H; Ishii S J Neurochem; 1980 Oct; 35(4):963-71. PubMed ID: 6778968 [TBL] [Abstract][Full Text] [Related]
38. Pharmacological study of TA-0910, a new thyrotropin-releasing hormone (TRH) analog, (I): Effects on the central nervous system by oral administration. Yamamura M; Kinoshita K; Nakagawa H; Tanaka T; Maeda K; Ishida R Jpn J Pharmacol; 1990 Aug; 53(4):451-61. PubMed ID: 2120494 [TBL] [Abstract][Full Text] [Related]
39. Modification of dopaminergic transmission by thyrotropin-releasing hormone. Narumi S; Nagawa Y Adv Biochem Psychopharmacol; 1983; 36():185-97. PubMed ID: 6305147 [TBL] [Abstract][Full Text] [Related]
40. Anticonvulsant effect of DN-1417, a derivative of thyrotropin-releasing hormone, and liposome-entrapped DN-1417, on amygdaloid-kindled rats. Mori N; Fukatsu T Epilepsia; 1992; 33(6):994-1000. PubMed ID: 1464282 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]